Wishing everyone a safe, healthy, and happy Fourth of July from all of us at G1 Therapeutics.
G1 Therapeutics, Inc.
Biotechnology Research
Research Triangle Park, NC 15,912 followers
Our mission is to discover, develop and deliver next generation cancer therapies.
About us
G1 Therapeutics, Inc. is a commercial-stage oncology company focused on the development and commercialization of next generation anti-cancer therapies. Led by a team with a deep understanding of the biology of cancer and extensive development and commercialization expertise, G1 is advancing its mission to improve the lives of those affected by cancer, including by commercializing the Company’s first commercial product, COSELA® (trilaciclib). G1 is also executing a development program, with a deep clinical pipeline evaluating targeted cancer therapies in a variety of solid tumors, including breast, lung, and bladder cancers. G1 Therapeutics is based in Research Triangle Park, N.C. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics. View our social community guidelines here: https://www.g1therapeutics.com/social-guidelines
- Website
-
http://www.g1therapeutics.com
External link for G1 Therapeutics, Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Research Triangle Park, NC
- Type
- Public Company
- Founded
- 2008
- Specialties
- Cancer / Oncology, Drug Discovery and Development, and Biotechnology
Locations
-
Primary
700 Park Offices Drive
Suite 200
Research Triangle Park, NC 27709, US
Employees at G1 Therapeutics, Inc.
Updates
-
G1 has joined the broad-market Russell 3000® and the small cap Russell 2000® Indexes as of market open today as part of the 2024 Russell US Indexes annual reconstitution. Learn more here: https://bit.ly/3L6h5Fr #RussellRecon
-
-
#NationalCancerSurvivorsMonth honors those who have triumphed over cancer, brings attention to their ongoing challenges, and supports efforts to advance cancer survivorship research. Join us in celebrating and learn more here: https://bit.ly/3wUgJ12. #NCSD24
-
-
Chemotherapy kills cancer cells. It can also kill healthy cells that grow fast, like the major types of blood cells that come from your bone marrow. When this occurs, it can be serious to your health. Learn more: https://bit.ly/3TfbelY.
-
-
Today we honor #Juneteenth, a commemoration of the end of slavery in the United States, and a day of reflection on the importance of pursuing equality, liberty, opportunity, and justice for all.
-
-
Once a #TripleNegative #BreastCancer (#TNBC) diagnosis has been made, the cancer cells will be checked for certain proteins, including HER2. To learn more, visit the American Cancer Society: https://bit.ly/3PQXCvL.
-
-
Today we’re recognizing #WorldBloodDonorDay (#WBDD), a movement advocating for the provision of safe blood and blood products to individuals all over the world. Learn how you can get involved: https://bit.ly/3PgYx80.
-
-
In June, we celebrate #NationalPrideMonth, a time for us to reflect on the achievements of the #LGBTQ+ community and to express our solidarity in their ongoing fight for equality.
-
-
If you've just been diagnosed with #LungCancer, open communication with your healthcare team is key. Ask questions, express concerns, and explore treatment options together. Learn what questions to ask from GO2 for Lung Cancer: https://bit.ly/3PpimtI.
-
-
We’re in Chicago at #ASCO24 today, presenting the mature results of our Phase 2 clinical trial results of our investigational therapy with an antibody-drug conjugate in #TNBC. You can view the poster here: https://bit.ly/4bTOxdN
-